Camptothecin-incorporating N-phthaloylchitosan-g-mPEG self-assembly micellar system: Effect of degree of deacetylation

Colloids and Surfaces B: Biointerfaces

Volumn 60, Issue 1, 2007, Pages 117-124

  Opanasopit, Praneet ^a   Ngawhirunpat, Tanasait ^a   Rojanarata, Theerasak ^a   Choochottiros, Chantiga ^b   Chirachanchai, Suwabun ^b  

^a SILPAKORN UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Camptothecin; Degree of deacetylation; N Phthaloylchitosan; Polymeric micelles

Indexed keywords

CAMPTOTHECIN; DEGREE OF DEACETYLATION; N-PHTHALOYLCHITOSAN; POLYMERIC MICELLES;

COPOLYMERS; ETHERS; MICELLES; NANOPARTICLES; SELF ASSEMBLY; TRANSMISSION ELECTRON MICROSCOPY;

POLYETHYLENE GLYCOLS;

AMPHOPHILE; CAMPTOTHECIN; CHITOSAN; CHITOSAN DERIVATIVE; COPOLYMER; N PHTHALOYLCHITOSAN POLY(ETHYLENE GLYCOL)METHYL ETHER; NANOPARTICLE; UNCLASSIFIED DRUG; WATER;

ARTICLE; CELL LINE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; DEACETYLATION; DIALYSIS; DRUG RELEASE; ELECTRON MICROSCOPE; HUMAN; HUMAN CELL; LIGHT SCATTERING; MICELLE; MICELLIZATION; MOLECULAR STABILITY; PARTICLE SIZE; PRIORITY JOURNAL; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

ACETYLATION; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CHITOSAN; DRUG DELIVERY SYSTEMS; MICELLES; NANOSTRUCTURES; POLYETHYLENE GLYCOLS;

EID: 34548124620     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2007.06.001     Document Type: Article

References (33)

1. Tuzar Z., and Kratochvil P. Block and graft copolymer micelles in solution. Adv. Colloid Interface Sci. 6 (1976) 201-232
2. Greish K., Fang J., Inutsuka T., Nagamitsu A., and Maeda H. Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting. Clin. Pharmacokinet. 42 (2003) 1089-1105
3. Lim S.H., and Hudson S.M. Review of chitosan and its derivatives as antimicrobial agents and their uses as textile chemicals. J. Macromol. Sci.: Polym. Rev. C43 (2003) 223-269
4. Okamoto Y., Yano R., Miyatake K., Tomohiro I., Shigemasa Y., and Minami S. Effects of chitin and chitosan on blood coagulation. Carbohydr. Polym. 53 (2003) 337-342
5. Rabea E.I., Badawy M.E.T., Stevens C.V., Smagghe G., and Steurbaut W. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules 4 (2003) 1457-1465
6. Lloyd L.L., Kennedy J.F., Methacanon P., Paterson M., and Knill C.J. Carbohydrate polymers as wound management aids. Carbohydr. Polym. 37 (1998) 315-322
7. Hertzberg R.P., Caranfa M.J., and Hecht S.M. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Biochemistry 28 (1989) 4629-4638
8. Fassberg J., and Stella V.J. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J. Pharm. Sci. 81 (1992) 676-684
9. Lundberg B.B. Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions. Anticancer Drug Des. 13 (1998) 453-461
10. Liu X., Lynn B.C., Zhang J., Song L., Bom D., Du W., Curran D.P., and Burke T.G. A versatile prodrug approach for liposomal core-loading of water-insoluble camptothecin anticancer drugs. J. Am. Chem. Soc. 124 (2002) 7650-7661
11. Ertl B., Platzer P., Wirth M., and Gabor F. Poly(dl-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin. J. Controlled Release 61 (1999) 305-317
12. Kumar V., Kang J., and Hohl R.J. Improved dissolution and cytotoxicity of camptothecin incorporated into oxidized-cellulose microspheres prepared by spray drying. Pharm. Dev. Technol. 6 (2001) 459-467
13. Tong W., Wang L., and D'Souza M.J. Evaluation of PLGA microspheres as delivery system for antitumor agent-camptothecin. Drug Dev. Ind. Pharm. 29 (2003) 745-756
14. Conover C.D., Greenwald R.B., Pendri A., and Shum K.L. Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs. Anticancer Drug Des. 14 (1999) 499-506
15. Singer J.W., De Vries P., Bhatt R., Tulinsky J., Klein P., Li C., Milas L., Lewis R.A., and Wallace S. Conjugation of camptothecins to poly-(L-glutamic acid). Ann. N. Y. Acad. Sci. 922 (2000) 136-150
16. Qiu B., Williams G.C., Sinko P., Stein S., and Minko T. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J. Controlled Release 91 (2003) 61-73
17. Dharap S.S., Wang Y., Chandna P., Khandare J.J., Qiu B., Gunaseelan S., Sinko P.J., Stein S., Farmanfarmaian A., and Minko T. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 12962-12967
18. Paranjpe P.V., Stein S., and Sinko P.J. Tumor-targeted and activated bioconjugates for improved camptothecin delivery. Anticancer Drugs 16 (2005) 763-775
19. Tyner K.M., Schiffman S.R., and Giannelis E.P. Nanobiohybrids as delivery vehicles for camptothecin. J. Controlled Release 95 (2004) 501-514
20. Opanasopit P., Yokoyama M., Watanabe M., Kawano K., Maitani Y., and Okano T. Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. Pharm. Res. 21 (2004) 2001-2008
21. Yokoyama M., Opanasopit P., Okano T., Kawano K., and Maitani Y. Polymer design and incorporation methods for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin. J. Drug Target 12 (2004) 373-384
22. Mu L., Elbayoumi T.A., and Torchilin V.P. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int. J. Pharm. 306 (2005) 142-149
23. Opanasopit P., Yokoyama M., Watanabe M., Kawano K., Maitani Y., and Okano T. Influence of serum and albumins from different species on stability of camptothecin-loaded micelles. J. Controlled Release 104 (2005) 313-321
24. Watanabe M., Kawano K., Yokoyama M., Opanasopit P., Okano T., and Maitani Y. Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability. Int. J. Pharm. 308 (2006) 183-189
25. Harish Prashanth K.V., and Tharanathan R.N. Studies on graft copolymerization of chitosan with synthetic monomers. Carbohydr. Polym. 54 (2003) 343-351
26. Sashiwa H., and Aiba S.I. Chemically modified chitin and chitosan as biomaterials. Prog. Polym. Sci. 29 (2004) 887-908
27. Miwa A., Ishibe A., Nakano M., Yamahira T., Itai S., Jinno S., and Kawahara H. Development of novel chitosan derivatives as micellar carriers of taxol. Pharm. Res. 15 (1998) 1844-1850
28. Zhang C., Qineng P., and Zhang H. Self-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar system. Colloids Surf. Biointerfaces 39 (2004) 69-75
29. Yoksan R., Matsusaki M., Akashi M., and Chirachanchai S. Controlled hydrophobic/hydrophilic chitosan: colloidal phenomena and nanosphere formation. Colloid Polym. Sci. 282 (2004) 337-342
30. Opanasopit P., Ngawhirunpat T., Chaidedgumjorn A., Rojanarata T., Apirakaramwong A., Phongying S., Choochottiros C., and Chirachanchai S. Incorporation of camptothecin into N-phthaloyl chitosan-g-mpeg self-assembly micellar system. Eur. J. Pharm. Biopharm. 60 (2006) 645-651
31. Mosmann T. Rapid colorimetric assay for cellular growth and survival-application to proliferation and cyto-toxicity assays. J. Immunol. Method 65 (1983) 55-63
32. Zhao C., Wang Y., Winnik M.A., Riess G., and Croucher M.D. Fluorescence probe technique used to study micelle formation in water-soluble block co-polymer. Langmuir 6 (1990) 514-516
33. Schipper N.G., Varum K.m., and Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs. 1. Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm. Res. 13 (1996) 1686-1692